Biotoxtech Co Ltd
KOSDAQ:086040
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Senshukai Co Ltd
TSE:8165
|
JP |
|
Sincere Navigation Corp
TWSE:2605
|
TW |
|
Guangzhou Wondfo Biotech Co Ltd
SZSE:300482
|
CN |
|
Harbin Pharmaceutical Group Co Ltd
SSE:600664
|
CN |
|
J
|
Jiangsu Huachen Transformer Co Ltd
SSE:603097
|
CN |
Biotoxtech Co Ltd
Total Current Liabilities
Biotoxtech Co Ltd
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
Biotoxtech Co Ltd
KOSDAQ:086040
|
Total Current Liabilities
₩82.6B
|
CAGR 3-Years
15%
|
CAGR 5-Years
32%
|
CAGR 10-Years
16%
|
|
|
Samsung Biologics Co Ltd
KRX:207940
|
Total Current Liabilities
₩3.8T
|
CAGR 3-Years
-3%
|
CAGR 5-Years
45%
|
CAGR 10-Years
N/A
|
|
|
A
|
ADM Korea Inc
KOSDAQ:187660
|
Total Current Liabilities
₩10.5B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
P
|
Peptron Inc
KOSDAQ:087010
|
Total Current Liabilities
₩7.3B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
10%
|
|
|
S
|
ST Pharm Co Ltd
KOSDAQ:237690
|
Total Current Liabilities
₩164.8B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
55%
|
CAGR 10-Years
N/A
|
|
|
L
|
LegoChem Biosciences Inc
KOSDAQ:141080
|
Total Current Liabilities
₩61.1B
|
CAGR 3-Years
29%
|
CAGR 5-Years
34%
|
CAGR 10-Years
21%
|
|
Biotoxtech Co Ltd
Glance View
Biotoxtech Co., Ltd. engages in the provision of non-clinical drug trials. The company is headquartered in Cheongju, Chungcheongbuk-Do. The company went IPO on 2007-09-21. The firm provides safety evaluation research, efficacy evaluation research and analysis research. Its safety evaluation research business provides general toxicity tests, local toxicity tests, reproductive and development tests, genotoxicity tests, immunotoxicity tests, carcinogenicity tests, safety pharmacology tests, ecotoxicology tests, histopathology tests and hematology tests. Its efficacy evaluation research business provides efficacy evaluation of medical supplies, health supplements and cosmetics. Its analysis research business provides pharmacokinetics (PK) tests and toxicokinetics (TK) tests services, as well as validation and bio analysis services. On March 13, 2013, the Company acquired a 60% stake in its new established subsidiary.
See Also
What is Biotoxtech Co Ltd's Total Current Liabilities?
Total Current Liabilities
82.6B
KRW
Based on the financial report for Sep 30, 2025, Biotoxtech Co Ltd's Total Current Liabilities amounts to 82.6B KRW.
What is Biotoxtech Co Ltd's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
16%
Over the last year, the Total Current Liabilities growth was -5%. The average annual Total Current Liabilities growth rates for Biotoxtech Co Ltd have been 15% over the past three years , 32% over the past five years , and 16% over the past ten years .
